Autologous Osteo-periosteal Cylinder Graft Transplantation for Hepple V Osteochondral Lesions of the Talus
Clinical Study of Autologous Osteo-periosteal Cylinder Graft Transplantation for Hepple V Osteochondral Lesions of the Talus
1 other identifier
interventional
70
1 country
1
Brief Summary
The trial evaluates the clinical efficacy and safety of autologous osteo-periosteal cylinder graft transplantation for Hepple V osteochondral lesions of the talus. Half of participants will receive autologous osteo-periosteal cylinder graft transplantation, while the other will receive osteochondral graft transplantation as a control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2017
CompletedFirst Posted
Study publicly available on registry
November 20, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 27, 2025
June 1, 2025
9 years
November 15, 2017
August 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
American Orthopaedic Foot & Ankle Society(AOFAS) ankle-hindfoot score
American Orthopaedic Foot \& Ankle Society(AOFAS) ankle-hindfoot score. The higher score represent the better outcome.
4 years
Secondary Outcomes (4)
International Cartilage Repair Society(ICRS) score
4 years
Magnetic Resonance Observation of cartilage repair tissue(MOCART) score
4 years
Tegner activity level score
4 years
Visual analogue scale
4 years
Study Arms (2)
autologous bone-periosteal graft
EXPERIMENTALThe patients in experimental group will undergo the surgery of arthroscopic repair Hepple V osteochondral lesions of the talus with autologous osteo-periosteal cylinder graft transplantation.
autologous osteochondral graft
ACTIVE COMPARATORThe patients in control group will undergo the surgery of arthroscopic repair Hepple V osteochondral lesions of the talus with autologous osteochondral graft transplantation.
Interventions
Autologous osteo-periosteal cylinder graft transplantation is a novel treatment for Hepple V osteochondral lesions of the talus.
Autologous osteochondral graft transplantation is the most common treatment for Hepple V osteochondral lesions of the talus.
Autologous osteo-periosteal cylinder graft is taken from ilium.
Eligibility Criteria
You may qualify if:
- years old, male or female
- Chronic pain in the ankle, confirmed by ankle joint MRI as Hepple V osteo-chondral lesions of the talus
- Using rest/external use/oral non-steroidal anti-inflammatory drugs and other conservative treatment for more than 3 months ineffective
- Patients voluntarily participated in clinical trials, signed informed consent, with clinical follow-up
You may not qualify if:
- In the last 6 months patients participated in other drug or medical device clinical trials
- Line of force in ankle is not correct (varus or valgus\> 5 degrees)
- Grade III ankle collateral ligament injury
- Chronic specific synovitis (rheumatoid, pigmented villonodular synovitis, etc.)
- Joint fibrosis, ankylosis, activity was significantly limited
- Moderate and severe osteoarthritis
- There are MRI contraindications
- Hemophilia patients
- The general condition of patients can not tolerate surgery
- Pregnant or planned pregnant women and lactating women
- Abnormal mental capacity without autonomy
- Other conditions in which the doctor can not decide to participate in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sports Medicine
Beijing, Beijing Municipality, 100000, China
Related Publications (2)
Yang S, Hu F, Shao Q, Zhang Z, Liu X, Jiang Y, Jiang D, Xie X, Jiao C, Hu Y, Shi W, Guo Q. Autologous Osteoperiosteal Transplantation Versus Autologous Osteochondral Transplantation for Large Cystic Osteochondral Lesions of the Medial Talus: 2-Year Results From a Prospective Randomized Controlled Trial. Am J Sports Med. 2025 Sep;53(11):2642-2651. doi: 10.1177/03635465251361505. Epub 2025 Aug 19.
PMID: 40828751DERIVEDDeng E, Shi W, Jiang Y, Guo Q. Comparison of autologous osteoperiosteal cylinder and osteochondral graft transplantation in the treatment of large cystic osteochondral lesions of the talus (OLTs): a protocol for a non-inferiority randomised controlled trial. BMJ Open. 2020 Feb 9;10(2):e033850. doi: 10.1136/bmjopen-2019-033850.
PMID: 32041859DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Qinwei Guo
Peking University Third Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Clinical Associate Professor and Chief Orthopedist of Orthopedic Sports Medicine
Study Record Dates
First Submitted
November 15, 2017
First Posted
November 20, 2017
Study Start
January 1, 2018
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 27, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share